Vitiligo Treatment Market Research Report - Global Forecast till 2025

Vitiligo Treatment Market Research Report - Global Forecast till 2025

ID: MRFR/HC/6970-HCR | November, 2019 | Region: Global | 111 pages | Half-Cooked Research Reports

Market Forecast


Vitiligo Treatment Market is expected to cross USD 1.84 Billion by 2025 at a CAGR of 5.6%.


Market Synopsis


Vitiligo is a pigmentation disorder in which the skin's pigment-making cells known as melanocytes are lost or destroyed. As a result of which, well-defined white patches appear on the skin. Patches may occur on one section or all over the body and later may join together.


Market Influencer


Increasing prevalence of investments by government bodies on healthcare infrastructure is positively influencing the global vitiligo treatment market.


Market Drivers



  • More than 150,000 Americans across all age groups were treated for vitiligo in 2013, and the cost of the treatment was more than USD 328 per patient, which is three times more than rosacea and twice more than acne treatments. It is estimated that the prevalence of vitiligo is around 1-2% worldwide. Thus, the increasing number of vitiligo cases is driving the vitiligo treatment market.

  • Changing lifestyle

  • Growing awareness among the population

  • Development of new novel therapy and drug discovery

  • The increasing number of clinical trials

  • The growing importance of the aesthetic appeal

  • Increasing disposable income in developing countries

  • Mergers & acquisitions

  • Technological advancements in the treatment methods

  • Increasing government support for research and development.


Market Restraints



  • Lack of trained professionals to handle the equipment is hampering the market.

  • Product recalls

  • Stringent regulations imposed by the government bodies on medical device manufacturers is also hindering the growth of the vitiligo treatment market.


Segmentation


By Type




  • non-segmental Vitiligo: It is also known as generalized or bilateral vitiligo. It is the largest segment as the occurrence of non-segmental vitiligo is 9 out of 10 people.




  • Segmental vitiligo: It is also known as unilateral vitiligo. It spreads rapidly in the affected areas.




By Treatment Type




  • Therapy: The therapy is further segmented into light therapy and de-pigmentation.




  • Surgery: Skin grafting, blister grafting are the types of surgery for treating vitiligo.




  • Medication: It is forecasted to be the largest segment due to the number of FDA approvals, drugs in the pipeline, and the cost of vitiligo treatment through medication is less as compared to the other treatment methods.




By End-User




  • Hospitals: The largest segment, hospitals are usually the primary points for diagnosis, treatment, and rehabilitation of individuals suffering from ailments or injuries. Growing awareness and increasing efficiency of medical services are projected to drive the growth of this segment during the forecast period.




  • Aesthetic Clinics: These clinics are widely known for improving cosmetic appearance.




By Region




  • Americas: The largest regional market. The prevalence of vitiligo is high in the Americas; the region also has a well-established healthcare industry.




  • Europe: It is estimated to be the second-largest market, due to the presence of key manufacturers and increasing research and development funding along with the undergoing rigorous clinical trial.




  • Asia-Pacific: The fastest-growing regional market, Asia-Pacific, is witnessing a surge in the number of people undergoing treatments for vitiligo, and many market players are investing in the Asia-Pacific region as it has a population of approximately 4.3 billion people.




  • Middle East & Africa: The smallest market due to limited healthcare infrastructure, the dearth of technological advancements in the pharmaceutical sector.




Key Players



  • Novartis AG (Basel, Basel-Stadt)

  • Allergan, Inc. (Dublin, Coolock)

  • Clinuvel Pharmaceuticals Limited (Melbourne, Victoria)

  • Astellas Pharma Inc. (Northbrook, IL)

  • Bausch Health Companies Inc. (Laval, Quebec)

  • STRATA Skin Sciences (Horsham, PA)

  • Reddy’s Laboratories Ltd. (India)

  • Eli Lilly Company (Indianapolis, Indiana)

  • Incyte Corporation (Wilmington, Delaware)

  • AstraZeneca AB (Cambridge, Cambridgeshire)

  • Epizyme, Inc. (Cambridge, MA)

  • Baxter International Inc. (Deerfield, Illinois)

  • Pfizer Inc. (New York)

Table of Contents

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Overview

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Vitiligo Treatment Market, by Type

6.1 Overview

6.2 Segmental

6.3 Non-segmental

Chapter 7. Global Vitiligo Treatment Market, by Treatment Type

7.1 Overview

7.2 Therapy

7.2.1 Depigmentation

7.2.2 Light

7.3 Surgery

7.3.1 Skin grafting

7.3.2 Blister grafting

7.3.3 Micro-pigmentation

7.4 Medication

7.4.1 Topical Corticosteroids

7.4.2 Immunosuppressive

Chapter 8. Global Vitiligo Treatment Market, by End User

8.1 Overview

8.2 Hospitals

8.3 Ambulatory Clinics

8.4 Others

Chapter 9. Global Vitiligo Treatment Market, by Region

9.1 Overview

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 Latin America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

Chapter 10. Competitive Landscape

10.1 Overview

10.2 Market Share Analysis

10.3 Key Developments & Strategies

10.3.1 Key Developments

Chapter 11. Company Profiles

11.1 Astellas Pharma Inc.

11.1.1. Company Overview

11.1.2. Financial Overview

11.1.3. Products Offered

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2 Bausch Health Companies Inc.

11.2.1 Company Overview

11.2.2 Financial Overview

11.2.3 Products Offered

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.2.6 Key Strategies

11.3 Baxter International Inc.

11.3.1 Company Overview

11.3.2 Financial Overview

11.3.3 Products Offered

11.3.4 Key Developments

11.3.5 SWOT Analysis

11.3.6 Key Strategies

11.4 Pfizer Inc.

11.4.1 Company Overview

11.4.2 Financial Overview

11.4.3 Products Offered

11.4.4 Key Developments

11.4.5 SWOT Analysis

11.4.5 Key Strategies

11.5 STRATA Skin Sciences

11.5.1 Company Overview

11.5.2 Financial Overview

11.5.3 Products Offered

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.5.6 Key Strategies

11.6 Reddy’s Laboratories Ltd

11.6.1 Company Overview

11.6.2 Financial Overview

11.6.3 Products Offered

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.6.6 Key Strategies

11.7 Clinuvel Pharmaceutical

11.7.1 Company Overview

11.7.2 Financial Overview

11.7.3 Products Offered

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.7.6 Key Strategies

11.8 Incyte Corporation

11.8.1 Company Overview

11.8.2 Financial Overview

11.8.3 Products Offered

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.8.6 Key Strategies

11.9 Aclaris Therapeutics

11.9.1 Company Overview

11.9.2 Financial Overview

11.9.3 Products Offered

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.9.6 Key Strategies

11.10 Allergan, Inc.

11.10.1 Company Overview

11.10.2 Financial Overview

11.10.3 Products Offered

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.10.6 Key Strategies

11.11 Novartis AG

11.11.1 Company Overview

11.11.2 Financial Overview

11.11.3 Products Offered

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.11.6 Key Strategies

11.12 Eli Lilly Company

11.12.1 Company Overview

11.12.2 Financial Overview

11.12.3 Products Offered

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.12.6 Key Strategies

11.13 Epizyme, Inc.

11.13.1 Company Overview

11.13.2 Financial Overview

11.13.3 Products Offered

11.13.4 Key Developments

11.13.5 SWOT Analysis

11.13.6 Key Strategies

Chapter 12. Appendix

12.1. References

12.2. Related Reports


LIST OF TABLES

Table 1 Global Vitiligo Treatment Synopsis, 2019–2025

Table 2 Global Vitiligo Treatment Market Estimates & Forecast, 2019–2025, (USD Million)

Table 3 Global Vitiligo Treatment Market, by Region, 2019–2025 (USD Million)

Table 4 Global Vitiligo Treatment Market, by Type, 2019–2025 (USD Million)

Table 5 Global Vitiligo Treatment Market, by Treatment Type, 2019–2025 (USD Million)

Table 6 Global Vitiligo Treatment Market, by End User, 2019–2025 (USD Million)

Table 7 Americas: Vitiligo Treatment Market, by Type, 2019–2025 (USD Million)

Table 8 Americas: Vitiligo Treatment Market, by Treatment Type, 2019–2025 (USD Million)

Table 9 Americas: Vitiligo Treatment Market, by End User, 2019–2025 (USD Million)

Table 10 Americas: Vitiligo Treatment Market, by Region, 2019–2025 (USD Million)

Table 11 North America: Vitiligo Treatment Market, by Type, 2019–2025 (USD Million)

Table 12 North America: Vitiligo Treatment Market, by Treatment Type, 2019–2025 (USD Million)

Table 13 North America: Vitiligo Treatment Market, by End User, 2019–2025 (USD Million)

Table 14 Latin America: Vitiligo Treatment Market, by Type, 2019–2025 (USD Million)

Table 15 Latin America: Vitiligo Treatment Market, by Treatment Type, 2019–2025 (USD Million)

Table 16 Latin America: Vitiligo Treatment Market, by End User, 2019–2025 (USD Million)

Table 17 Europe: Vitiligo Treatment Market, by Type, 2019–2025 (USD Million)

Table 18 Europe: Vitiligo Treatment Market, by Treatment Type, 2019–2025 (USD Million)

Table 19 Europe: Vitiligo Treatment Market, by End User, 2019–2025 (USD Million)

Table 20 Europe: Vitiligo Treatment Market, by Region, 2019–2025 (USD Million)

Table 21 Western Europe: Vitiligo Treatment Market, by Type, 2019–2025 (USD Million)

Table 22 Western Europe: Vitiligo Treatment Market, by Treatment Type, 2019–2025 (USD Million)

Table 23 Western Europe: Vitiligo Treatment Market, by End User, 2019–2025 (USD Million)

Table 24 Eastern Europe: Vitiligo Treatment Market, by Type, 2019–2025 (USD Million)

Table 25 Eastern Europe: Vitiligo Treatment Market, by Treatment Type, 2019–2025 (USD Million)

Table 26 Eastern Europe: Vitiligo Treatment Market, by End User, 2019–2025 (USD Million)

Table 27 Asia-Pacific: Vitiligo Treatment Market, by Type, 2019–2025 (USD Million)

Table 28 Asia-Pacific: Vitiligo Treatment Market, by Treatment Type, 2019–2025 (USD Million)

Table 29 Asia-Pacific: Vitiligo Treatment Market, by End User, 2019–2025 (USD Million)

Table 30 Middle East & Africa: Vitiligo Treatment Market, by Type, 2019–2025 (USD Million)

Table 31 Middle East & Africa: Vitiligo Treatment Market, by Treatment Type, 2019–2025 (USD Million)

Table 32 Middle East & Africa: Vitiligo Treatment Market, by End User, 2019–2025 (USD Million)


LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation of the Global Vitiligo Treatment Market

Figure 3 Market Dynamics for the Global Vitiligo Treatment Market

Figure 4 Global Vitiligo Treatment Market Share, by Type, 2018

Figure 5 Global Vitiligo Treatment Market Share, by Treatment Type, 2018

Figure 6 Global Vitiligo Treatment Market Share, by End User, 2018

Figure 7 Global Vitiligo Treatment Market Share, by Region, 2018

Figure 8 Americas: Vitiligo Treatment Market Share, by Region, 2018

Figure 9 North America: Vitiligo Treatment Market Share, by Country, 2018

Figure 10 Latin America: Vitiligo Treatment Market Share, by Country, 2018

Figure 11 Europe: Vitiligo Treatment Market Share, by Country, 2018

Figure 12 Asia-Pacific: Vitiligo Treatment Market Share, by Country, 2018

Figure 13 Middle East & Africa: Vitiligo Treatment Market Share, by Country, 2018

Figure 14 Global Vitiligo Treatment Market: Company Share Analysis, 2018 (%)

Figure 15 Astellas Pharma Inc.: Key Financials

Figure 16 Astellas Pharma Inc.: Segmental Revenue

Figure 17 Astellas Pharma Inc.: Regional Revenue

Figure 18 Bausch Health Companies Inc.: Key Financials

Figure 19 Bausch Health Companies Inc.: Segmental Revenue

Figure 20 Bausch Health Companies Inc.: Regional Revenue

Figure 21 Baxter International Inc.: Key Financials

Figure 22 Baxter International Inc.: Segmental Revenue

Figure 23 Baxter International Inc.: Regional Revenue

Figure 24 Pfizer Inc.: Key Financials

Figure 25 Pfizer Inc.: Segmental Revenue

Figure 26 Pfizer Inc.: Regional Revenue

Figure 27 STRATA Skin Sciences: Key Financials

Figure 28 STRATA Skin Sciences: Regional Revenue

Figure 29 STRATA Skin Sciences: Key Financials

Figure 30 Reddy’s Laboratories Ltd.: Segmental Revenue

Figure 31 Reddy’s Laboratories Ltd.: Regional Revenue

Figure 32 Reddy’s Laboratories Ltd.: Key Financials

Figure 33 Aclaris Therapeutics: Segmental Revenue

Figure 34 Aclaris Therapeutics: Regional Revenue

Figure 35 Aclaris Therapeutics: Key Financials

Figure 36 Eli Lilly Company: Segmental Revenue

Figure 37 Eli Lilly Company: Regional Revenue

Figure 38 Eli Lilly Company: Key Financials

Figure 39 Clinuvel Pharmaceutical: Segmental Revenue

Figure 40 Clinuvel Pharmaceutical: Regional Revenue

Figure 41 Clinuvel Pharmaceutical: Key Financials

Figure 42 Incyte Corporation.: Segmental Revenue

Figure 43 Incyte Corporation: Regional Revenue

Figure 44 Incyte Corporation: Key Financials

Figure 42 Epizyme, Inc.: Segmental Revenue

Figure 43 Epizyme, Inc.: Regional Revenue

Figure 44 Epizyme, Inc.: Key Financials

Figure 42 Allergan, Inc.: Segmental Revenue

Figure 43 Allergan, Inc.: Regional Revenue

Figure 44 Allergan, Inc.: Key Financials

Figure 42 Novartis AG: Segmental Revenue

Figure 43 Novartis AG: Regional Revenue

Figure 44 Novartis AG: Key Financials



This table of content is tentative and subject to change as the research progresses.

Please note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.

Vitiligo Treatment Market